Cor Vasa 2014, 56(6):689-691

Postavení beta-blokátorů u pacientů s arteriální hypertenzí a metabolickými poruchami

Prof. MUDr. Hana Rosolová, DrSc., FESC
Centrum preventivní kardiologie, II. interní klinika, Lékařská fakulta Plzeň, Univerzita Karlova v Praze a Fakultní nemocnice Plzeň, Plzeň

Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rosolová H. Postavení beta-blokátorů u pacientů s arteriální hypertenzí a metabolickými poruchami. Cor Vasa. 2014;56(6):689-691.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. J. Filipovský, J. Widimský jr., J. Ceral, et al., členové výboru ČSH, Diagnostika a léčbě arteriální hypertenze 2012, Doporučení České společnosti pro hypertenzi, Vnitřní lékařství 58 (2012) 785-801. Go to PubMed...
    2. B. Dahlöf, P.S. Sever, N.R. Poulter, et al., Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial, Lancet 366 (2005) 895-906. Go to original source... Go to PubMed...
    3. S. Nodari, M. Mehra, L. Dei Cas, Beta blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized comparison of the long-term effects of atenolol vs nebivolol, European Journal of Heart Failure 5 (2003) 621-627. Go to original source... Go to PubMed...
    4. H.G. Predel, W. Mainka, W. Schillings, et al., Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension, Journal of Human Hypertension 15 (2001) 715-721. Go to original source... Go to PubMed...
    5. M.D. Flather, M.C. Shibata, A.J. Coats, et al., SENIORS Investigators, Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS), European Heart Journal 26 (2005) 215-225. Go to original source... Go to PubMed...
    6. E. Agabiti Rosei, D. Rizzoni, Metabolic profile of nebivolol, a b-adrenoceptor antagonist with unique characteristics, Drugs 67 (2007) 1097-1107. Go to original source... Go to PubMed...
    7. M. Cazzola, P. Noschese, M. D'Amato, G. D'Amato, Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma, Chest 118 (2000) 1322-1326. Go to original source... Go to PubMed...
    8. R.W. Dal Negro, S. Tognella, C. Micheletto, Pharmacokinetics of the effect of nebivolol 5mg on airway patency in patients with mild to moderate bronchial Asthma and Arterial Hypertension: A Randomised, Placebo-Controlled Study, Clinical Drug Investigation 22 (3) (2002) 197-204. Go to original source...
    9. A.C. Schmidt, C. Graf, K. Brixius, et al., Blood Pressure-Lowering Effect of Nebivolol in Hypertensive Patients with Type 2 Diabetes Mellitus, the YESTONO Study, Clinical Drug Investigation 27 (2007) 841-849. Go to original source... Go to PubMed...
    10. A.I. Adler, I.M. Stratton, H.A. Neil, et al., Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study, British Medical Journal 321 (2000) 412-419. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes